Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Market Cap	1.31T +21.7%
Revenue (ttm)	546.57B +9.7%
Net Income	60.08B +2.7%
EPS	6,437.95 +2.7%
Shares Out	9.33M
PE Ratio	21.73
Forward PE	n/a
Dividend	2,400.00 (1.67%)
Ex-Dividend Date	Nov 21, 2025

Volume	118
Average Volume	540
Open	144,000
Previous Close	n/a
Day's Range	144,000 - 144,000
52-Week Range	100,200 - 189,000
Beta	-0.20
RSI	48.98
Earnings Date	Apr 17, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company manufactures and sells pharmaceutical products in Vietnam. The company offers over the counter drug products, such as medicines from medicinal herbs; minerals and vitamins; eye, ENT, and cough treatment; disinfectants; anti-allergic drugs; gastrointestinal and hepatobiliary drugs; external medications; drugs to treat parasites and bacterial infections analgesic, antipyretic, anti-inflammatory, and gout treatment; cardiovascular and diabetes; and psychoactive drugs. It is also involved in th...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 516
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 60.08 billion, an increase of 2.71%.